Quadrant Capital Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-457
| Closed | -$1.52K | – | 2727 |
|
|
2023
Q4 | $1.52K | Buy |
+457
| New | +$1.52K | ﹤0.01% | 2514 |
|
|
2023
Q1 | – | Sell |
-21
| Closed | -$166 | – | 2729 |
|
|
2022
Q4 | $166 | Hold |
21
| – | – | ﹤0.01% | 2705 |
|
|
2022
Q3 | $0 | Hold |
21
| – | – | ﹤0.01% | 2650 |
|
|
2022
Q2 | $0 | Buy |
21
+9
| +75% | – | ﹤0.01% | 2559 |
|
|
2022
Q1 | $0 | Sell |
12
-16
| -57% | – | ﹤0.01% | 2516 |
|
|
2021
Q4 | $0 | Hold |
28
| – | – | ﹤0.01% | 2533 |
|
|
2021
Q3 | $0 | Buy |
28
+10
| +56% | – | ﹤0.01% | 2524 |
|
|
2021
Q2 | $0 | Sell |
18
-8
| -31% | – | ﹤0.01% | 2427 |
|
|
2021
Q1 | $0 | Buy |
+26
| New | – | ﹤0.01% | 2388 |
|